SATT Sud-Est
Overview
SATT Sud-Est is a technology transfer accelerator that develops and funds innovations from public research in the Provence-Alpes-Côte d'Azur and Corsica regions of France, with the goal of commercializing them through licensing or startup creation.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| KeeeX | Jun 2017 | Seed | Co-investor |
| Massalia Therapeutics | May 2025 | Seed | Co-investor |
| DimiCare Biotech | Nov 2025 | Grant | Co-investor |
| Optipus PV | May 2025 | Seed | Co-investor |
| Neocor Therapeutics | Jan 2024 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is SATT Sud-Est based?
SATT Sud-Est is headquartered in Marseille, France.
When was SATT Sud-Est founded?
SATT Sud-Est was founded in 2012.
How many portfolio companies does SATT Sud-Est have?
SATT Sud-Est has 7 portfolio companies in Caplight's dataset.
What are some companies in SATT Sud-Est's portfolio?
Portfolio companies visible on Caplight include KeeeX, Massalia Therapeutics, DimiCare Biotech, Optipus PV, Neocor Therapeutics.
What was SATT Sud-Est's most recent investment shown here?
SATT Sud-Est's most recent investment in this portfolio sample was in DimiCare Biotech in 2025.
What sectors does SATT Sud-Est focus on?
SATT Sud-Est focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Cybersecurity, Enterprise Software, Frontier & Industrial Tech, Energy & Sustainability.
What company stages does SATT Sud-Est focus on?
SATT Sud-Est typically invests at the Early stage.